A Pharmaceutical Firm Bets Big On A Cancer Drug

The Economist: Business, The Economist
Thu, 02/22/2018 - 8:47am

WHEN Ken Frazier, chief executive of Merck, an American pharmaceutical giant, started his job in 2011, he had a hard decision to make. The firm had promising new drugs—such as Januvia, for diabetes, and Gardasil, a vaccine against cervical cancer. But the pharma industry was struggling with dismal returns on R&D and investors were questioning if companies were overspending on science.

NEXT
Topics:  ken frazier   american   januvia   gardasil   mr frazier   schering-plough   merck s   merck   r&d   pharmaceutical   firm   cancer drug   started   drugs   
BING NEWS:
  • Pharma Billionaire's Fortune More Than Doubles In A Day On Cancer Drug Trial News
    Positive clinical trial results for a drug candidate to treat lung cancer sent shares of this unprofitable biotech firm soaring–and turbocharged Robert Duggan’s net worth.
    05/30/2024 - 6:47 pm | View Link
  • Pound surges as summer rate cut hopes vanish
    The pound is on track for its best month since November as hopes of a summer interest rate cut dwindle. Sterling is up 1.8pc against the dollar so far this month to trade at more than $1.27, which ...
    05/24/2024 - 6:06 am | View Link
  • Global Pharma Giants Are Betting Big On Oncology But Without Daring To Tackle Cancer Prevention
    Oncology is the pharma’s newest shinning star in the post-Covid-19 era. Pfizer Inc (NYSE: PFE) prioritized its oncology focus as its newest plan includes the revamping of this department.  Pfizer is ...
    05/22/2024 - 4:37 am | View Link
  • Biocon’s formulations business to outpace API share soon: CEO
    Biocon’s momentum in its formulations business balanced the challenges it faced in pricing pressures on its API (active pharmaceutical ingredient) business and could soon overtake the share of APIs in ...
    05/19/2024 - 9:32 pm | View Link
  • Q1 2024 Eli Lilly and Co Earnings Call
    White; EVP & President of Lilly Neuroscience; Eli Lilly and Company Daniel M. Skovronsky; EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology; Eli Lilly and ...
    04/30/2024 - 8:25 pm | View Link
  • More

 

NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News